← Leaderboards
Meenakshi Arora
University Of Alabama In Tuscaloosa
$1,991,584
Attributed
$3,983,168
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $790.5K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,983,168 · 2
By mechanism
R01$3,983,168 · 2
Top collaborators
- Ravikumar N Majeti11 shared
Most similar at University Of Alabama In Tuscaloosa
Same institution · by research overlap
- Ravikumar N Majeti$5,267,104
- Chao Zhao$2,924,887
Others in their field
Other Emerging Leaders on “Nucleosome Core Particle”
- Robert Joseph Tomko · Florida State University$3,023,101
- Esma Alp · Kalocyte, Inc.$3,018,059
- Erik Debler · Thomas Jefferson University$2,795,048
- James Joseph Driscoll · Case Western Reserve University$2,506,922
- Ravikumar N Majeti · University Of Alabama In Tuscaloosa$2,495,377
- Ravi Kumar Anchoori · Up Therapeutics, Inc.$2,300,931
Research focus
Nucleosome Core ParticleRegimenEffective TherapyNanoparticlePharmaceutical PreparationsReceptorClinical ResearchDoseInflammatoryMouse ModelParticleBenchmarkingCarbonPolyestersClinicBiological AvailabilityDensityDesignFda ApprovedFormulationLengthLigandsOralSide Effect
Grant awards (11)
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$443,846
R01 · FY2025 · AI
Urolithin A nanoparticle therapy for acute kidney injury$323,152
R01 · FY2025 · DK
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$448,982
R01 · FY2024 · AI
Urolithin A nanoparticle therapy for acute kidney injury$310,226
R01 · FY2024 · DK
Urolithin A nanoparticle therapy for acute kidney injury$323,152
R01 · FY2023 · DK
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$450,986
R01 · FY2022 · AI
Urolithin A nanoparticle therapy for acute kidney injury$323,152
R01 · FY2022 · DK
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$467,374
R01 · FY2021 · AI
Urolithin A nanoparticle therapy for acute kidney injury$323,152
R01 · FY2021 · DK
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$488,039
R01 · FY2020 · AI
Engineering the next generation nanoparticle-cyclosporine A therapy in lupus$81,107
R01 · FY2020 · AI